Arts and Artifacts Indemnity Panel Advisory Committee, 33092-33093 [2019-14751]
Download as PDF
<![CDATA[
jspears on DSK30JT082PROD with NOTICES
33092
Federal Register / Vol. 84, No. 133 / Thursday, July 11, 2019 / Notices
www.reginfo.gov/public/do/
PRAViewICR?ref_nbr=201903-1240-003
(this link will only become active on the
day following publication of this notice)
or by contacting Frederick C. Licari by
telephone at 202–693–8073, TTY 202–
693–8064, (these are not toll-free
numbers) or by email at DOL_PRA_
PUBLIC@dol.gov.
Submit comments about this request
by mail to the Office of Information and
Regulatory Affairs, Attn: OMB Desk
Officer for DOL–OWCP, Office of
Management and Budget, Room 10235,
725 17th Street NW, Washington, DC
20503; by Fax: 202–395–5806 (this is
not a toll-free number); or by email:
OIRA_submission@omb.eop.gov.
Commenters are encouraged, but not
required, to send a courtesy copy of any
comments by mail or courier to the U.S.
Department of Labor-OASAM, Office of
the Chief Information Officer, Attn:
Departmental Information Compliance
Management Program, Room N1301,
200 Constitution Avenue NW,
Washington, DC 20210; or by email:
DOL_PRA_PUBLIC@dol.gov.
FOR FURTHER INFORMATION CONTACT:
Frederick C. Licari by telephone at 202–
693–8073, TTY 202–693–8064, (these
are not toll-free numbers) or by email at
DOL_PRA_PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: This ICR
seeks to extend PRA authorization for
the Pharmacy Billing Requirements
information collection. The OWCP is
the agency responsible for
administration of the Federal
Employees’ Compensation Act (FECA),
5 U.S.C. 8101 et seq.; the Black Lung
Benefits Act (BLBA), 30 U.S.C. 901 et
seq.; and the Energy Employees
Occupational Illness Compensation
Program Act of 2000 (EEOICPA), 42
U.S.C. 7384 et seq. All three of these
statutes require the OWCP to pay for
covered medical treatment provided to
beneficiaries; this medical treatment can
include medicinal drugs dispensed by
pharmacies. In order to determine
whether amounts billed for drugs are
appropriate, the OWCP must receive the
required data elements—including the
name of the patient/beneficiary, the
National Drug Code number of each
drug prescribed, the quantity provided,
the prescription number, and the date
the prescription was filled. The
regulations implementing these statutes
require the collection of information
needed to enable the OWCP to
determine whether bills for drugs
submitted directly by pharmacies or as
reimbursement requests submitted by
claimants should be paid. See 20 CFR
10.801, 30.701, 725.701, and 725.705.
FECA section 9, BLBA section 413, and
VerDate Sep<11>2014
18:46 Jul 10, 2019
Jkt 247001
EEOICPA section 3629(c) authorize this
information collection. See 5 U.S.C.
8103, 30 U.S.C. 936, and 42 U.S.C.
7384t.
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless it is
approved by the OMB under the PRA
and displays a currently valid OMB
Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information that does not
display a valid Control Number. See 5
CFR 1320.5(a) and 1320.6. The DOL
obtains OMB approval for this
information collection under Control
Number 1240–0050.
OMB authorization for an ICR cannot
be for more than three (3) years without
renewal, and the current approval for
this collection is scheduled to expire on
September 30, 2019. The DOL seeks to
extend PRA authorization for this
information collection for three (3) more
years, without any change to existing
requirements. The DOL notes that
existing information collection
requirements submitted to the OMB
receive a month-to-month extension
while they undergo review. For
additional substantive information
about this ICR, see the related notice
published in the Federal Register on
March 1, 2019 (84 FR 7133).
Interested parties are encouraged to
send comments to the OMB, Office of
Information and Regulatory Affairs at
the address shown in the ADDRESSES
section within thirty (30) days of
publication of this notice in the Federal
Register. In order to help ensure
appropriate consideration, comments
should mention OMB Control Number
1240–0050. The OMB is particularly
interested in comments that:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Agency: DOL–OWCP.
Title of Collection: Pharmacy Billing
Requirements.
OMB Control Number: 1240–0050.
Affected Public: Public Sector—
Businesses or other for-profits, Not-forprofit institutions.
Total Estimated Number of
Respondents: 4,146.
Total Estimated Number of
Responses: 1,381,903.
Total Estimated Annual Time Burden:
24,203 hours.
Total Estimated Annual Other Costs
Burden: $0.
Authority: 44 U.S.C. 3507(a)(1)(D).
Dated: July 3, 2019.
Michel Smyth,
Departmental Clearance Officer.
[FR Doc. 2019–14741 Filed 7–10–19; 8:45 am]
BILLING CODE 4510–CK–P
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES
Federal Council on the Arts and the
Humanities
Arts and Artifacts Indemnity Panel
Advisory Committee
Federal Council on the Arts
and the Humanities, National
Foundation on the Arts and the
Humanities.
ACTION: Notice of meeting.
AGENCY:
Pursuant to the Federal
Advisory Committee Act, notice is
hereby given that the Federal Council
on the Arts and the Humanities will
hold a meeting of the Arts and Artifacts
Domestic Indemnity Panel.
DATES: The meeting will be held on
Tuesday, August 6, 2019, from 12:00
p.m. to 5:00 p.m.
ADDRESSES: The meeting will be held by
teleconference originating at the
National Endowment for the Arts,
Washington, DC 20506.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Voyatzis, Committee
Management Officer, 400 7th Street SW,
Room 4060, Washington, DC 20506,
(202) 606–8322; evoyatzis@neh.gov.
SUPPLEMENTARY INFORMATION: The
purpose of the meeting is for panel
review, discussion, evaluation, and
recommendation on applications for
Certificates of Indemnity submitted to
the Federal Council on the Arts and the
Humanities, for exhibitions beginning
on or after October 1, 2019. Because the
SUMMARY:
E:\FR\FM\11JYN1.SGM
11JYN1
Federal Register / Vol. 84, No. 133 / Thursday, July 11, 2019 / Notices
meeting will consider proprietary
financial and commercial data provided
in confidence by indemnity applicants,
and material that is likely to disclose
trade secrets or other privileged or
confidential information, and because it
is important to keep the values of
objects to be indemnified, and the
methods of transportation and security
measures confidential, I have
determined that that the meeting will be
closed to the public pursuant to
subsection (c)(4) of section 552b of Title
5, United States Code. I have made this
determination under the authority
granted me by the Chairman’s
Delegation of Authority to Close
Advisory Committee Meetings, dated
April 15, 2016.
Dated: July 2, 2019.
Elizabeth Voyatzis,
Committee Management Officer, Federal
Council on the Arts and the Humanities &
Deputy General Counsel, National
Endowment for the Humanities.
[FR Doc. 2019–14751 Filed 7–10–19; 8:45 am]
BILLING CODE 7536–01–P
I. Obtaining Information and
Submitting Comments
NUCLEAR REGULATORY
COMMISSION
A. Obtaining Information
[Docket No. 50–289; NRC–2019–0142]
Exelon Generation Company LLC;
Three Mile Island Nuclear Station Unit
1; Post-Shutdown Decommissioning
Activities Report
Nuclear Regulatory
Commission.
ACTION: Notice of receipt; availability;
public meeting; and request for
comment.
AGENCY:
On April 5, 2019, the U.S.
Nuclear Regulatory Commission (NRC)
received the Post-Shutdown
Decommissioning Activities Report
(PSDAR) for the Three Mile Island
Nuclear Station, Unit 1 (TMI–1). The
PSDAR provides an overview of Exelon
Generation Company, LLC’s (Exelon or
the licensee) planned decommissioning
activities, schedule, projected costs, and
environmental impacts for TMI–1. The
NRC will hold a public meeting to
discuss the PSDAR’s content and
receive comments.
DATES: Submit comments by October 9,
2019. Comments received after this date
will be considered if it is practical to do
so, but the NRC is able to ensure
consideration only for comments
received before this date.
ADDRESSES: You may submit comments
by any of the following methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov/ and search
jspears on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:26 Jul 10, 2019
for Docket ID: NRC–2019–0142. Address
questions about NRC dockets IDs to
Jennifer Borges; telephone: 301–287–
9127; email: Jennifer.Borges@nrc.gov.
For technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• Mail comments to: Office of
Administration, Mail Stop: TWFN–7–
A60M, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001, ATTN: Program Management,
Announcements and Editing Staff.
For additional direction on obtaining
information and submitting comments,
see ‘‘Obtaining Information and
Submitting Comments’’ in the
SUPPLEMENTARY INFORMATION section of
this document.
FOR FURTHER INFORMATION CONTACT:
Justin C. Poole, Office of Nuclear
Reactor Regulation, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001, telephone: 301–415–
2048; email: Justin.Poole@nrc.gov.
SUPPLEMENTARY INFORMATION:
Jkt 247001
Please refer to Docket ID NRC–2019–
0142 when contacting the NRC about
the availability of information for this
action. You may obtain publiclyavailable information related to this
action by any of the following methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov/ and search
for Docket ID NRC–2019–0142.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
ADAMS accession number for each
document referenced (if it is available in
ADAMS) is provided the first time that
it is mentioned in this document.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
B. Submitting Comments
Please include Docket ID NRC–2019–
0142 in your comment submission.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
33093
The NRC cautions you not to include
identifying or contact information that
you do not want to be publicly
disclosed in your comment submission.
The NRC will post all comment
submissions at https://
www.regulations.gov/ as well as enter
the comment submissions into ADAMS.
The NRC does not routinely edit
comment submissions to remove
identifying or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the NRC, then you should
inform those persons not to include
identifying or contact information that
they do not want to be publicly
disclosed in their comment submission.
Your request should state that the NRC
does not routinely edit comment
submissions to remove such information
before making the comment
submissions available to the public or
entering the comment submissions into
ADAMS.
II. Discussion
Exelon is the holder of Renewed
Facility Operating License No. DPR–50
for TMI–1. The license provides, among
other things, that the facility is subject
to all rules, regulations, and orders of
the NRC now or hereafter in effect. The
facility consists of one pressurizedwater reactor located in Dauphin
County, Pennsylvania. By letter dated
June 20, 2017 (ADAMS Accession No.
ML17171A151), the licensee submitted
Certification of Permanent Cessation of
Power Operations for TMI–1. In this
letter, Exelon notified the NRC of its
intent to permanently cease operations
at TMI–1 no later than September 30,
2019.
On April 5, 2019, Exelon submitted
the PSDAR for TMI–1, in accordance
with § 50.82(a)(4)(i) of title 10 of the
Code of Federal Regulations (ADAMS
Accession No. ML19095A041). The
PSDAR includes a description of the
planned decommissioning activities, a
proposed schedule for their
accomplishment, the expected
decommissioning and spent fuel
management costs, and a discussion that
provides the basis for concluding that
the environmental impacts associated
with the site-specific decommissioning
activities will be bounded by
appropriate, previously issued generic
and plant-specific environmental
impact statements. In separate letters,
Exelon submitted its Site Specific
Decommissioning Cost Estimate and
Spent Fuel Management Plan for TMI–
1 on April 5, 2019 (ADAMS Accession
Nos. ML19095A010 and ML19095A009,
respectively).
E:\FR\FM\11JYN1.SGM
11JYN1
]]>Agencies
[Federal Register Volume 84, Number 133 (Thursday, July 11, 2019)]
[Notices]
[Pages 33092-33093]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14751]
=======================================================================
-----------------------------------------------------------------------
NATIONAL FOUNDATION ON THE ARTS AND THE HUMANITIES
Federal Council on the Arts and the Humanities
Arts and Artifacts Indemnity Panel Advisory Committee
AGENCY: Federal Council on the Arts and the Humanities, National
Foundation on the Arts and the Humanities.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: Pursuant to the Federal Advisory Committee Act, notice is
hereby given that the Federal Council on the Arts and the Humanities
will hold a meeting of the Arts and Artifacts Domestic Indemnity Panel.
DATES: The meeting will be held on Tuesday, August 6, 2019, from 12:00
p.m. to 5:00 p.m.
ADDRESSES: The meeting will be held by teleconference originating at
the National Endowment for the Arts, Washington, DC 20506.
FOR FURTHER INFORMATION CONTACT: Elizabeth Voyatzis, Committee
Management Officer, 400 7th Street SW, Room 4060, Washington, DC 20506,
(202) 606-8322; [email protected].
SUPPLEMENTARY INFORMATION: The purpose of the meeting is for panel
review, discussion, evaluation, and recommendation on applications for
Certificates of Indemnity submitted to the Federal Council on the Arts
and the Humanities, for exhibitions beginning on or after October 1,
2019. Because the
[[Page 33093]]
meeting will consider proprietary financial and commercial data
provided in confidence by indemnity applicants, and material that is
likely to disclose trade secrets or other privileged or confidential
information, and because it is important to keep the values of objects
to be indemnified, and the methods of transportation and security
measures confidential, I have determined that that the meeting will be
closed to the public pursuant to subsection (c)(4) of section 552b of
Title 5, United States Code. I have made this determination under the
authority granted me by the Chairman's Delegation of Authority to Close
Advisory Committee Meetings, dated April 15, 2016.
Dated: July 2, 2019.
Elizabeth Voyatzis,
Committee Management Officer, Federal Council on the Arts and the
Humanities & Deputy General Counsel, National Endowment for the
Humanities.
[FR Doc. 2019-14751 Filed 7-10-19; 8:45 am]
BILLING CODE 7536-01-P
